Thomas Luft

Nov 27, 2023 | nature.com | Evren Bayraktar |Francis Ayuk |Gernot Beutel |Olaf Penack |Thomas Luft |Gastone Castellani | +3 more

AbstractDespite advances in allogeneic hematopoietic cell transplantation, acute graft-versus-host disease (aGVHD) remains its leading complication, yet with heterogeneous outcomes. Here, we analyzed aGVHD phenotypes and clinical classifications in depth in large, multicenter cohorts involving 3019 patients and addressed prevailing gaps by developing data-driven models.